Global and Japan Prostate Cancer Drugs Market Insights, Forecast to 2027

Global and Japan Prostate Cancer Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Prostate Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Drugs Market Size Growth Rate by Type
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Drugs Market Size Growth Rate by Application
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Prostate Cancer Drugs Revenue 2016-2027
2.1.2 Global Prostate Cancer Drugs Sales 2016-2027
2.2 Global Prostate Cancer Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Prostate Cancer Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Prostate Cancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Prostate Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Prostate Cancer Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Prostate Cancer Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Prostate Cancer Drugs Revenue Forecast by Region (2022-2027)
3 Global Prostate Cancer Drugs Competitor Landscape by Players
3.1 Global Top Prostate Cancer Drugs Manufacturers by Sales
3.1.1 Global Prostate Cancer Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Prostate Cancer Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Prostate Cancer Drugs Manufacturers by Revenue
3.2.1 Key Prostate Cancer Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Prostate Cancer Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Prostate Cancer Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Prostate Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Prostate Cancer Drugs Revenue in 2020
3.2.6 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Prostate Cancer Drugs Price by Manufacturers
3.4 Global Prostate Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Prostate Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prostate Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Prostate Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Prostate Cancer Drugs Market Size by Type (2016-2021)
4.1.1 Global Prostate Cancer Drugs Sales by Type (2016-2021)
4.1.2 Global Prostate Cancer Drugs Revenue by Type (2016-2021)
4.1.3 Prostate Cancer Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Prostate Cancer Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Prostate Cancer Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Prostate Cancer Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Prostate Cancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Prostate Cancer Drugs Market Size by Application (2016-2021)
5.1.1 Global Prostate Cancer Drugs Sales by Application (2016-2021)
5.1.2 Global Prostate Cancer Drugs Revenue by Application (2016-2021)
5.1.3 Prostate Cancer Drugs Price by Application (2016-2021)
5.2 Prostate Cancer Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Prostate Cancer Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Prostate Cancer Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Prostate Cancer Drugs Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Prostate Cancer Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Prostate Cancer Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Prostate Cancer Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Prostate Cancer Drugs Market Share in Global Market 2016-2027
6.2 Japan Prostate Cancer Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Prostate Cancer Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Prostate Cancer Drugs Players by Revenue (2016-2021)
6.3 Japan Prostate Cancer Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Prostate Cancer Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Prostate Cancer Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Prostate Cancer Drugs Price by Type (2016-2021)
6.4 Japan Prostate Cancer Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Prostate Cancer Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Prostate Cancer Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Prostate Cancer Drugs Price Forecast by Type (2022-2027)
6.5 Japan Prostate Cancer Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Prostate Cancer Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Prostate Cancer Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Prostate Cancer Drugs Price by Application (2016-2021)
6.6 Japan Prostate Cancer Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Prostate Cancer Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Prostate Cancer Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Prostate Cancer Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Prostate Cancer Drugs Market Size YoY Growth 2016-2027
7.2 North America Prostate Cancer Drugs Market Facts & Figures by Country
7.2.1 North America Prostate Cancer Drugs Sales by Country (2016-2021)
7.2.2 North America Prostate Cancer Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Prostate Cancer Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Prostate Cancer Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Prostate Cancer Drugs Market Size YoY Growth 2016-2027
9.2 Europe Prostate Cancer Drugs Market Facts & Figures by Country
9.2.1 Europe Prostate Cancer Drugs Sales by Country (2016-2021)
9.2.2 Europe Prostate Cancer Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Prostate Cancer Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Prostate Cancer Drugs Market Facts & Figures by Country
10.2.1 Latin America Prostate Cancer Drugs Sales by Country (2016-2021)
10.2.2 Latin America Prostate Cancer Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Prostate Cancer Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Prostate Cancer Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Prostate Cancer Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AbbVie
12.1.1 AbbVie Corporation Information
12.1.2 AbbVie Description and Business Overview
12.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AbbVie Prostate Cancer Drugs Products Offered
12.1.5 AbbVie Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Corporation Information
12.2.2 Astellas Pharma Description and Business Overview
12.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Astellas Pharma Prostate Cancer Drugs Products Offered
12.2.5 Astellas Pharma Recent Development
12.3 Astra Zeneca
12.3.1 Astra Zeneca Corporation Information
12.3.2 Astra Zeneca Description and Business Overview
12.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Astra Zeneca Prostate Cancer Drugs Products Offered
12.3.5 Astra Zeneca Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Description and Business Overview
12.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Prostate Cancer Drugs Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi Prostate Cancer Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Corporation Information
12.6.2 GlaxoSmithKline Description and Business Overview
12.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 GlaxoSmithKline Prostate Cancer Drugs Products Offered
12.6.5 GlaxoSmithKline Recent Development
12.7 Merck Group
12.7.1 Merck Group Corporation Information
12.7.2 Merck Group Description and Business Overview
12.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Group Prostate Cancer Drugs Products Offered
12.7.5 Merck Group Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Description and Business Overview
12.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Prostate Cancer Drugs Products Offered
12.8.5 Novartis Recent Development
12.9 Amgen
12.9.1 Amgen Corporation Information
12.9.2 Amgen Description and Business Overview
12.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Amgen Prostate Cancer Drugs Products Offered
12.9.5 Amgen Recent Development
12.10 Bayer HealthCare
12.10.1 Bayer HealthCare Corporation Information
12.10.2 Bayer HealthCare Description and Business Overview
12.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bayer HealthCare Prostate Cancer Drugs Products Offered
12.10.5 Bayer HealthCare Recent Development
12.11 AbbVie
12.11.1 AbbVie Corporation Information
12.11.2 AbbVie Description and Business Overview
12.11.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AbbVie Prostate Cancer Drugs Products Offered
12.11.5 AbbVie Recent Development
12.12 Janssen Pharmaceuticals
12.12.1 Janssen Pharmaceuticals Corporation Information
12.12.2 Janssen Pharmaceuticals Description and Business Overview
12.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Janssen Pharmaceuticals Products Offered
12.12.5 Janssen Pharmaceuticals Recent Development
12.13 Endo Pharmaceuticals
12.13.1 Endo Pharmaceuticals Corporation Information
12.13.2 Endo Pharmaceuticals Description and Business Overview
12.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Endo Pharmaceuticals Products Offered
12.13.5 Endo Pharmaceuticals Recent Development
12.14 BMS
12.14.1 BMS Corporation Information
12.14.2 BMS Description and Business Overview
12.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 BMS Products Offered
12.14.5 BMS Recent Development
12.15 Takeda Pharmaceuticals
12.15.1 Takeda Pharmaceuticals Corporation Information
12.15.2 Takeda Pharmaceuticals Description and Business Overview
12.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Takeda Pharmaceuticals Products Offered
12.15.5 Takeda Pharmaceuticals Recent Development
12.16 Northwest Biotherapeutics
12.16.1 Northwest Biotherapeutics Corporation Information
12.16.2 Northwest Biotherapeutics Description and Business Overview
12.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Northwest Biotherapeutics Products Offered
12.16.5 Northwest Biotherapeutics Recent Development
12.17 Teva Pharmaceutical
12.17.1 Teva Pharmaceutical Corporation Information
12.17.2 Teva Pharmaceutical Description and Business Overview
12.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Teva Pharmaceutical Products Offered
12.17.5 Teva Pharmaceutical Recent Development
12.18 Boehringer Ingelheim
12.18.1 Boehringer Ingelheim Corporation Information
12.18.2 Boehringer Ingelheim Description and Business Overview
12.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Boehringer Ingelheim Products Offered
12.18.5 Boehringer Ingelheim Recent Development
12.19 Foresee Pharmaceuticals
12.19.1 Foresee Pharmaceuticals Corporation Information
12.19.2 Foresee Pharmaceuticals Description and Business Overview
12.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Foresee Pharmaceuticals Products Offered
12.19.5 Foresee Pharmaceuticals Recent Development
12.20 Tokai Pharmaceuticals
12.20.1 Tokai Pharmaceuticals Corporation Information
12.20.2 Tokai Pharmaceuticals Description and Business Overview
12.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Tokai Pharmaceuticals Products Offered
12.20.5 Tokai Pharmaceuticals Recent Development
12.21 Spectrum Pharmaceuticals
12.21.1 Spectrum Pharmaceuticals Corporation Information
12.21.2 Spectrum Pharmaceuticals Description and Business Overview
12.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Spectrum Pharmaceuticals Products Offered
12.21.5 Spectrum Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Prostate Cancer Drugs Industry Trends
13.2 Prostate Cancer Drugs Market Drivers
13.3 Prostate Cancer Drugs Market Challenges
13.4 Prostate Cancer Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prostate Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Hormonal Therapy
Table 3. Major Manufacturers of Chemotherapy
Table 4. Major Manufacturers of Immunotherapy
Table 5. Major Manufacturers of Targeted Therapy
Table 6. Global Prostate Cancer Drugs Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 7. Global Prostate Cancer Drugs Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Prostate Cancer Drugs Sales by Regions (2016-2021) & (K MT)
Table 9. Global Prostate Cancer Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Prostate Cancer Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Prostate Cancer Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 12. Global Prostate Cancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Prostate Cancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Prostate Cancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Prostate Cancer Drugs Sales by Manufacturers (2016-2021) (K MT)
Table 16. Global Prostate Cancer Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Prostate Cancer Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Prostate Cancer Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Prostate Cancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Drugs as of 2020)
Table 22. Key Manufacturers Prostate Cancer Drugs Price (2016-2021) (USD/MT)
Table 23. Prostate Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Prostate Cancer Drugs Product Type
Table 25. Date of International Manufacturers Enter into Prostate Cancer Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Prostate Cancer Drugs Sales by Type (2016-2021) (K MT)
Table 28. Global Prostate Cancer Drugs Sales Share by Type (2016-2021)
Table 29. Global Prostate Cancer Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Prostate Cancer Drugs Revenue Share by Type (2016-2021)
Table 31. Prostate Cancer Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 32. Global Prostate Cancer Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 33. Global Prostate Cancer Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Prostate Cancer Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Prostate Cancer Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Prostate Cancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 37. Global Prostate Cancer Drugs Sales by Application (2016-2021) (K MT)
Table 38. Global Prostate Cancer Drugs Sales Share by Application (2016-2021)
Table 39. Global Prostate Cancer Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Prostate Cancer Drugs Revenue Share by Application (2016-2021)
Table 41. Prostate Cancer Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 42. Global Prostate Cancer Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 43. Global Prostate Cancer Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Prostate Cancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Prostate Cancer Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Prostate Cancer Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 47. Japan Prostate Cancer Drugs Sales (K MT) of Key Companies (2016-2021)
Table 48. Japan Prostate Cancer Drugs Sales Share by Company (2016-2021)
Table 49. Japan Prostate Cancer Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. Japan Prostate Cancer Drugs Revenue Share by Company (2016-2021)
Table 51. Japan Prostate Cancer Drugs Sales (K MT) by Type (2016-2021)
Table 52. Japan Prostate Cancer Drugs Sales Share by Type (2016-2021)
Table 53. Japan Prostate Cancer Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. Japan Prostate Cancer Drugs Price (USD/MT) by Type (2016-2021)
Table 55. Japan Prostate Cancer Drugs Sales (K MT) by Type (2022-2027)
Table 56. Japan Prostate Cancer Drugs Sales Share by Type (2022-2027)
Table 57. Japan Prostate Cancer Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. Japan Prostate Cancer Drugs Revenue Share by Type (2022-2027)
Table 59. Japan Prostate Cancer Drugs Price (USD/MT) by Type (2022-2027)
Table 60. Japan Prostate Cancer Drugs Sales (K MT) by Application (2016-2021)
Table 61. Japan Prostate Cancer Drugs Sales Share by Application (2016-2021)
Table 62. Japan Prostate Cancer Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. Japan Prostate Cancer Drugs Price (USD/MT) by Application (2016-2021)
Table 64. Japan Prostate Cancer Drugs Sales (K MT) by Application (2022-2027)
Table 65. Japan Prostate Cancer Drugs Sales Share by Application (2022-2027)
Table 66. Japan Prostate Cancer Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. Japan Prostate Cancer Drugs Revenue Share by Application (2022-2027)
Table 68. Japan Prostate Cancer Drugs Price (USD/MT) by Application (2022-2027)
Table 69. North America Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 70. North America Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Prostate Cancer Drugs Sales by Region (2016-2021) & (K MT)
Table 74. Asia Pacific Prostate Cancer Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Prostate Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Prostate Cancer Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 78. Europe Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 82. Latin America Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 86. Middle East and Africa Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 89. AbbVie Corporation Information
Table 90. AbbVie Description and Business Overview
Table 91. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 92. AbbVie Prostate Cancer Drugs Product
Table 93. AbbVie Recent Development
Table 94. Astellas Pharma Corporation Information
Table 95. Astellas Pharma Description and Business Overview
Table 96. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 97. Astellas Pharma Product
Table 98. Astellas Pharma Recent Development
Table 99. Astra Zeneca Corporation Information
Table 100. Astra Zeneca Description and Business Overview
Table 101. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 102. Astra Zeneca Product
Table 103. Astra Zeneca Recent Development
Table 104. Johnson & Johnson Corporation Information
Table 105. Johnson & Johnson Description and Business Overview
Table 106. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Recent Development
Table 109. Sanofi Corporation Information
Table 110. Sanofi Description and Business Overview
Table 111. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. Sanofi Product
Table 113. Sanofi Recent Development
Table 114. GlaxoSmithKline Corporation Information
Table 115. GlaxoSmithKline Description and Business Overview
Table 116. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. GlaxoSmithKline Product
Table 118. GlaxoSmithKline Recent Development
Table 119. Merck Group Corporation Information
Table 120. Merck Group Description and Business Overview
Table 121. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 122. Merck Group Product
Table 123. Merck Group Recent Development
Table 124. Novartis Corporation Information
Table 125. Novartis Description and Business Overview
Table 126. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 127. Novartis Product
Table 128. Novartis Recent Development
Table 129. Amgen Corporation Information
Table 130. Amgen Description and Business Overview
Table 131. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 132. Amgen Product
Table 133. Amgen Recent Development
Table 134. Bayer HealthCare Corporation Information
Table 135. Bayer HealthCare Description and Business Overview
Table 136. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 137. Bayer HealthCare Product
Table 138. Bayer HealthCare Recent Development
Table 139. Ferring Pharmaceutical Corporation Information
Table 140. Ferring Pharmaceutical Description and Business Overview
Table 141. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 142. Ferring Pharmaceutical Product
Table 143. Ferring Pharmaceutical Recent Development
Table 144. Janssen Pharmaceuticals Corporation Information
Table 145. Janssen Pharmaceuticals Description and Business Overview
Table 146. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Janssen Pharmaceuticals Product
Table 148. Janssen Pharmaceuticals Recent Development
Table 149. Endo Pharmaceuticals Corporation Information
Table 150. Endo Pharmaceuticals Description and Business Overview
Table 151. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Endo Pharmaceuticals Product
Table 153. Endo Pharmaceuticals Recent Development
Table 154. BMS Corporation Information
Table 155. BMS Description and Business Overview
Table 156. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 157. BMS Product
Table 158. BMS Recent Development
Table 159. Takeda Pharmaceuticals Corporation Information
Table 160. Takeda Pharmaceuticals Description and Business Overview
Table 161. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 162. Takeda Pharmaceuticals Product
Table 163. Takeda Pharmaceuticals Recent Development
Table 164. Northwest Biotherapeutics Corporation Information
Table 165. Northwest Biotherapeutics Description and Business Overview
Table 166. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 167. Northwest Biotherapeutics Product
Table 168. Northwest Biotherapeutics Recent Development
Table 169. Teva Pharmaceutical Corporation Information
Table 170. Teva Pharmaceutical Description and Business Overview
Table 171. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 172. Teva Pharmaceutical Product
Table 173. Teva Pharmaceutical Recent Development
Table 174. Boehringer Ingelheim Corporation Information
Table 175. Boehringer Ingelheim Description and Business Overview
Table 176. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 177. Boehringer Ingelheim Product
Table 178. Boehringer Ingelheim Recent Development
Table 179. Foresee Pharmaceuticals Corporation Information
Table 180. Foresee Pharmaceuticals Description and Business Overview
Table 181. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 182. Foresee Pharmaceuticals Product
Table 183. Foresee Pharmaceuticals Recent Development
Table 184. Tokai Pharmaceuticals Corporation Information
Table 185. Tokai Pharmaceuticals Description and Business Overview
Table 186. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 187. Tokai Pharmaceuticals Product
Table 188. Tokai Pharmaceuticals Recent Development
Table 189. Spectrum Pharmaceuticals Corporation Information
Table 190. Spectrum Pharmaceuticals Description and Business Overview
Table 191. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 192. Spectrum Pharmaceuticals Product
Table 193. Spectrum Pharmaceuticals Recent Development
Table 194. Prostate Cancer Drugs Market Trends
Table 195. Prostate Cancer Drugs Market Drivers
Table 196. Prostate Cancer Drugs Market Challenges
Table 197. Prostate Cancer Drugs Market Restraints
Table 198. Prostate Cancer Drugs Customers List
Table 199. Prostate Cancer Drugs Distributors List
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Drugs Product Picture
Figure 2. Global Prostate Cancer Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Hormonal Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Targeted Therapy Product Picture
Figure 7. Global Prostate Cancer Drugs Sales Market Share by Application in 2020 & 2027
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs